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REPORT
Regulation of ETAA1-mediated ATR activation
couples DNA replication fidelity and genome
stability
Divya Achuthankutty1,2*, Roshan Singh Thakur2*, Peter Haahr1*, Saskia Hoffmann1, Alexandros P. Drainas3, Anna H. Bizard2, JoachimWeischenfeldt4,
Ian D. Hickson2, and Niels Mailand1,2
The ATR kinase is a master regulator of the cellular response to DNA replication stress. Activation of ATR relies on dual
pathways involving the TopBP1 and ETAA1 proteins, both of which harbor ATR-activating domains (AADs). However, the exact
contribution of the recently discovered ETAA1 pathway to ATR signaling in different contexts remains poorly understood.
Here, using an unbiased CRISPR-Cas9–based genome-scale screen, we show that the ATR-stimulating function of ETAA1
becomes indispensable for cell fitness and chromosome stability when the fidelity of DNA replication is compromised. We
demonstrate that the ATR-activating potential of ETAA1 is controlled by cell cycle– and replication stress–dependent
phosphorylation of highly conserved residues within its AAD, and that the stimulatory impact of these modifications is
required for the ability of ETAA1 to prevent mitotic chromosome abnormalities following replicative stress. Our findings
suggest an important role of ETAA1 in protecting against genome instability arising from incompletely duplicated DNA via
regulatory control of its ATR-stimulating potential.
Introduction
The ATR kinase plays a crucial role in normal physiology by
functioning as an apical organizer of the cellular response to
DNA replication stress, a deleterious condition caused by the
slowing or stalling of replication forks (Saldivar et al., 2017).
Replication stress is a recognized driver of genome instability
that can fuel the development of cancer and other severe pa-
thologies (Branzei and Foiani, 2010; Ciccia and Elledge, 2010;
Zeman and Cimprich, 2014). ATR-dependent phosphorylation of
a range of downstream effector proteins collectively enables
cells to prevent the collapse of stalled replication forks and
suppress the firing of new replication origins until the replica-
tive stress has been resolved (Saldivar et al., 2017).
Stimulation of ATR kinase activity entails the recruitment of
ATR and its partner protein ATRIP to replication protein A
(RPA)–coated stretches of single-stranded DNA, which accu-
mulate upon functional uncoupling of replicative DNA helicase
and polymerase activities after replication fork stalling (Zou and
Elledge, 2003; Saldivar et al., 2017). This brings ATR-ATRIP into
close proximity with TopBP1, which is independently recruited
to replication stress sites via the Rad9-Rad1-Hus1 complex and
directly stimulates ATR kinase activity by means of an ATR-
activating domain (AAD; Kumagai et al., 2006; Delacroix et al.,
2007; Lee et al., 2007). While the requirement of this pathway
for promoting the essential ATR–CHK1 checkpoint signaling axis
has long been recognized, recent findings revealed that the
ETAA1 protein independently promotes ATR signaling by means
of dual RPA-binding motifs and an AAD that stimulates ATR
kinase activity via a mechanism analogous to that of the TopBP1
AAD (Bass et al., 2016; Haahr et al., 2016; Lee et al., 2016; Thada
and Cortez, 2019). Loss of ETAA1 sensitizes cells to replication
stress and is synthetic lethal with TopBP1 depletion, resulting
from quantitative suppression of ATR signaling, defective G2/M
checkpoint control, and ensuing gross chromosomal instability
(Haahr et al., 2016). Thus, full ATR activation in vertebrate cells
relies on independent TopBP1- and ETAA1-mediated pathways,
although the precise division of labor in promoting ATR-
mediated signaling responses remains unclear. For instance,
while ablation of TopBP1 or the functionality of its AAD leads
to early embryonic lethality in mice, ETAA1 knockout (KO)
gives rise to a comparatively mild phenotype characterized by
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incompletely penetrant embryonic lethality, reduced body size,
and defective clonal expansion of T lymphocytes (Zhou et al.,
2013; Miosge et al., 2017). Recent studies suggested roles of
ETAA1 in promoting an ATR-mediated S/G2 checkpoint sup-
pressing mitotic entry before completion of DNA replication and
ATR activation during mitosis, where ATR has been shown to
facilitate Aurora B activation at centromeres and accurate
chromosome segregation (Kabeche et al., 2018; Saldivar et al.,
2018; Bass and Cortez, 2019). However, it remains unclear
which, if any, of these activities represents the key cellular
functions of ETAA1 in maintaining chromosome stability. In
addition, whether and how the ATR-activating capacity of
ETAA1 is modulated by DNA replication and genome integrity
status are not known.
Here, we used an unbiased genome-scale CRISPR-Cas9
screening approach to reveal a specific and critical function of
ETAA1 in promoting cell fitness and chromosome stability upon
genetic or chemical disruption of DNA replication efficiency. We
established a central role in this process of cell cycle– and rep-
lication stress–regulated, phosphorylation-dependent control of
ETAA1-mediated ATR activation.
Results and discussion
ETAA1 becomes critical for cell fitness upon disruption of the
DNA replication machinery
To define the key cellular functions of human ETAA1, we per-
formed an unbiased, genome-scale, CRISPR-Cas9–based screen
to identify genes whose ablation is synthetic lethal with loss of
ETAA1 expression. To this end, we transduced WT and ETAA1-
deficient (ETAA1Δ) HeLa cells (Haahr et al., 2016) with a lenti-
viral CRISPR-Cas9 KO single guide RNA (sgRNA) library (GeCKO
v2) targeting 19,050 human genes (Sanjana et al., 2014).We then
used next-generation sequencing to identify sgRNAs that were
selectively depleted in the ETAA1Δ background upon long-term
proliferation (Fig. 1 A and Fig. S1 A). Among genes whose KO
selectively impaired proliferation of ETAA1Δ cells, we identified
several factors with known roles in promoting DNA synthesis,
including MCM10, POLE3, POLE4, and CDC25A (Bartek et al.,
2004; Chadha et al., 2016; Bellelli et al., 2018), while sgRNAs
targeting essential DNA replication factors including prolifer-
ating cell nuclear antigen and CMG helicase subunits were de-
pleted in both WT and ETAA1Δ cells as expected (Fig. 1, B and C;
Fig. S1 B; and Table S1). Gene ontology analysis indicated notable
enrichment of terms associated with DNA replication and cell
cycle progression among gene KOs displaying synthetic lethality
with ETAA1 loss (Fig. 1 D), suggesting that ETAA1 function be-
comes critical when DNA replication efficiency is compromised.
Knockdown ofMCM10 or POLE3 by siRNAs impaired clonogenic
survival to a much greater extent in HCT116 ETAA1Δ cells than in
their WT counterparts, validating these screen hits and dem-
onstrating that their genetic interaction with ETAA1 is not cell
type–specific (Fig. 1, E and F; and Fig. S1, C and D). Interestingly,
combined loss of ETAA1 and MCM10 led to a markedly elevated
proportion of cells undergoing mitosis in the presence of DNA
damage relative to MCM10 depletion alone (Fig. 1, G and H).
Moreover, upon low-dose treatment with the DNA polymerase
inhibitor aphidicolin (APH) to chemically slow down DNA rep-
lication, ETAA1Δ cells displayed a faster progression into mitosis
than did WT cells (Fig. 1 I). Together, these data suggest that
ETAA1 function becomes critical for cell fitness and genome
stability by restraining mitotic entry when DNA replication in-
tegrity is compromised.
ETAA1 prevents mitotic chromosome abnormalities associated
with under-replicated DNA
To explore the potential role of ETAA1 in preventing genetic
alterations arising from incompletely replicated DNA, we ana-
lyzed the impact of ETAA1 loss in HCT116 and HeLa cells on
mitotic chromosome abnormalities. For this, we quantified
bulky and ultrafine anaphase DNA bridges (UFBs) that are
hallmarks of unresolved replication intermediates (Mankouri
et al., 2013), during both an unperturbed cell cycle and follow-
ing replication stress induced by low-dose treatment with APH
or hydroxyurea (HU). Consistent with a role of ETAA1 in linking
DNA replication integrity and chromosome stability, ETAA1Δ
cells showed elevated frequencies of anaphase chromatin
bridges and lagging chromatin that were exacerbated upon
replicative stress (Fig. 2, A–C; and Fig. S1, E–H). Likewise,
ETAA1Δ cells displayed a pronounced increase in UFBs marked
by PICH and associated with FANCD2 twin foci (Fig. 2, A and
D–F; and Fig. S1, I and J), indicative of elevated common fragile
site (CFS) expression (Minocherhomji et al., 2015). In late G2
cells, ETAA1 colocalized with FANCD2 foci, which demarcate
CFSs, but not with centromeric or telomeric markers (Fig. S1 K),
suggesting a specific association of ETAA1 with UFBs arising
from under-replicated DNA. We also observed a subset of UFBs
that were coated by RPA (Fig. S1, L and M;Mankouri et al., 2013;
Chan et al., 2018), although we failed to detect ETAA1 associated
with these structures (data not shown), suggesting that it sup-
presses UFB formation by restricting mitotic entry of cells
containing incompletely duplicated loci. In agreement with this
possibility, cells lacking ETAA1 displayed an increased level of
metaphase chromosome breaks that was further enhanced fol-
lowing APH treatment (Fig. 2, A, G, and H). Moreover, ETAA1
KO led to a markedly elevated proportion of APH-treated and
MCM10-depleted cells undergoing mitotic DNA synthesis (Mi-
DAS; Fig. 2, A, I, and J; and Fig. S1 N), a process that resolves
under-replicated DNA at CFSs in early mitosis (Minocherhomji
et al., 2015). We conclude that ETAA1 is important for pre-
venting mitotic chromosome abnormalities arising from in-
completely replicated loci.
Cell cycle– and replication stress–regulated phosphorylation
of the ETAA1 AAD promotes its ATR-activating potential
In line with a role for ETAA1 in protecting against chromosome
instability arising from under-replicated DNA even during un-
perturbed cell proliferation, previous work by others and us
demonstrated that ETAA1 promotes ATR signaling in a normal S
phase (Haahr et al., 2016; Saldivar et al., 2018). Because ETAA1
harbors both RPA-binding and ATR-activating determinants and
might therefore be capable of promoting ATR activation irre-
spective of cell cycle position, we reasoned that regulatory
control of this functionmay be important for its integrationwith
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genome duplication status. The ATR-activating ability of TopBP1
can be stimulated by direct ATM-mediated phosphorylation
within its AAD (Yoo et al., 2007). Correspondingly, we noted
that the ETAA1 AAD contains highly conserved, putative CDK
phosphorylation sites (S95 and S111 in human ETAA1) in close
proximity to aromatic amino acids (F106 and W107) that are
essential for stimulation of ATR kinase activity (Fig. 3 A; Bass
et al., 2016; Haahr et al., 2016). Phospho-specific antibodies to
S95 and S111 in human ETAA1 showed that both residues are
phosphorylated in cells (Fig. 3, B and C; and Fig. S2 A). Inter-
estingly, whereas the levels of S95 and S111 phosphorylation
were low in asynchronous cells, these modifications were ro-
bustly up-regulated during S and G2 phases but declined as cells
entered mitosis (Fig. 3 C). Using an established high-content
imaging-based assay for monitoring ETAA1 AAD-mediated
ATR activation in cells (Haahr et al., 2016; Thada and Cortez,
2019), we found that phospho-mimicking substitutions at S95 or
S111 (S95D or S111D) but not other potential CDK sites within the
ETAA1 AAD (T79D and T165D) potentiated the ATR-activating
capacity of ectopic ETAA1 AAD expressed at low levels (Fig. 3 D
and Fig. S2 B). Combining the S95D and S111D substitutions
synergistically augmented this activity (Fig. 3 D and Fig. S2 B).
Moreover, unlike WT ETAA1, whose AAD we have previously
shown is a direct target of ATR-mediated phosphorylation
(Haahr et al., 2016), an S95A+S111A AAD phosphorylation-
deficient ETAA1 allele was refractory to phosphorylation by
ATR upon replication stress (Fig. 3 E and Fig. S2, A and C). These
observations suggested that phosphorylation of the ETAA1 AAD
stimulates its ATR-activating potential and interplay with ATR.
Interestingly, phosphorylation of S95 was strongly up-regulated
upon replication stress induced by camptothecin or HU (Fig. 3 F
and Fig. S2 D) in an ATR-dependent manner (Fig. 3 G and Fig. S2,
E and F), while S111 phosphorylation showed a mild increase,
indicating a potential positive feedback loop underlying ETAA1-
mediated ATR activation.
Next, we investigated whether S95 and S111 were phos-
phorylated by CDKs. In contrast to ATR inhibition, suppressing
interphase, but not mitotic, CDK activity strongly reduced the
basal cell cycle–dependent phosphorylation of S95 and S111,
but had no impact on the replication stress–induced hyper-
phosphorylation of S95 (Fig. 3 H and Fig. S2, F and G). More-
over, both S95 and S111 could be directly phosphorylated by
cyclin A–CDK2, but not ATR, in vitro (Fig. S2, H and I). Collec-
tively, these findings suggest that phosphorylation of S95 and
S111 during unperturbed S phase is directly catalyzed by CDKs,
while replication stress–induced hyperphosphorylation of S95 is
mediated by an ATR-dependent pathway involving an as yet
unknown non-CDK effector kinase.
AAD phosphorylation is critical for ETAA1-dependent
suppression of replication stress-induced chromosome
instability
We next asked whether the ETAA1 AAD and its phospho-
dependent regulation are required for suppressing chromo-
some instability following impaired DNA replication progression,
using a panel of ETAA1 KO cell lines stably reconstituted with
inducible WT or mutant forms of GFP-tagged ETAA1 (Fig. S3 A).
As expected, the mitotic chromosome abnormalities and in-
creased MiDAS resulting from ETAA1 loss could be rescued
by ectopic WT ETAA1, but not mutants lacking the AAD or
RPA-binding motifs (Fig. 4, A–E; and Fig. S3 B), providing a
framework for probing the importance of ETAA1 AAD phos-
phorylation in protecting against chromosomal aberrations.
Notably, similar to the ETAA1 ΔAAD and ΔRPA1+2 mutants, the
ETAA1 S95A+S111A mutant failed to efficiently reverse mitotic
chromosome aberrations and DNA synthesis in an ETAA1Δ
background, supporting a key role for AAD phosphorylation in
promoting ETAA1-mediated suppression of chromosome insta-
bility (Fig. 4, D–H; and Fig. S3 C). We previously demonstrated
that ETAA1 promotes cell survival following replication stress in
a manner dependent on both its AAD and dual RPA-binding
motifs (Haahr et al., 2016). Similarly, we found that stably re-
constituted ETAA1 S95A+S111A protein was unable to correct
the survival defect of ETAA1Δ cells exposed to replication
stress (Fig. 4 I). These data further support an important role of
phosphorylation-mediated regulation of ATR activation by
ETAA1 in promoting genome stability and cell fitness when DNA
replication integrity is challenged.
Our studies demonstrate that ETAA1 becomes critical for
chromosome stability and cell fitness under conditions of com-
promised DNA replication efficiency, and that phosphorylation-
mediated control of its ATR-stimulating potential is central to
this function. The notion that ETAA1 suppresses a range of mi-
totic chromosome abnormalities associated with incompletely
replicated DNA via its ATR-activating ability is well aligned with
recent work by others and us showing that ETAA1, but not
TopBP1, promotes ATR signaling during a normal S phase
(Haahr et al., 2016; Saldivar et al., 2018). Moreover, in contrast
to ETAA1, TopBP1 has been shown to localize to UFBs and pro-
mote MiDAS (Pedersen et al., 2015). This apparent division of
Figure 1. ETAA1 becomes critical for cell fitness upon disruption of the DNA replication machinery. (A) Schematic overview of CRISPR-Cas9 KO screen
workflow. (B) Volcano plot of CRISPR-Cas9 screen results, showing gene KOs that selectively impair fitness of HeLa WT (blue; P < 0.01) or ETAA1Δ (red; P <
0.01) cells. Point sizes (q value) represent the corrected P value for growth effect (−log10). Fold change depicts the median difference in sgRNA representation
between the two cell lines at t21. (C) Boxplot depicting normalized counts for selected screen hits. (D) Gene ontology (GO) analysis of sensitizing hits specific to
HeLa ETAA1Δ cells. (E) Clonogenic survival (relative to nontargeting control siRNA [siCTRL]) of HCT116 cell lines transfected with MCM10 siRNA (mean ± SEM;
n = 3 independent experiments; unpaired t test). (F) As in E, but using POLE3 siRNA (mean ± SEM; n = 3 independent experiments; unpaired t test).
(G) Representative images of siRNA-transfected cells coimmunostained with γ-H2AX and H3-pS10 antibodies. Scale bar, 10 µm. (H) Flow cytometry analysis of
γ-H2AX positivity in mitotic cells in G, gated based on DNA content and H3-pS10 positivity (mean ± SEM; n = 3 or 4 independent experiments; multiple t test).
(I) Cells synchronized by double thymidine block were released into medium containing nocodazole in the presence or absence of APH (0.2 µM), collected 12 h
later, and processed for flow cytometry to determine the relative mitotic index (APH/untreated) by H3-pS10 staining (mean ± SEM; n = 3 experiments; unpaired
t test). ***, P < 0.0005; **, P < 0.005; *, P < 0.05; ns, not significant.
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Figure 2. ETAA1 suppresses mitotic chromosome abnormalities associated with incompletely replicated DNA. (A) Workflow for analysis of mitotic
chromosome abnormalities. (B) Quantification of DAPI-positive chromatin bridges (example shown in inset) in anaphase HCT116 cells treated as in A (mean ±
SEM; n = 3 independent experiments; 100 anaphases/condition; unpaired t test). (C) As in B, except that the proportion of cells with lagging chromatin (inset)
was quantified (mean ± SEM; n = 3 independent experiments; 100 anaphases/condition; unpaired t test). (D) Representative images of PICH-coated UFBs in
anaphase HCT116 cells treated as in A and coimmunostained with PICH and FANCD2 antibodies. FANCD2 foci at UFB termini demarcating CFSs can be seen.
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labor between ETAA1 and TopBP1 has a notable analogy to the
distinct roles played by AAD-containing proteins in budding
yeast, where Dna2 promotes activation of the ATR homologue
Mec1 at RPA-coated single-stranded DNA on the lagging
strand during normal DNA replication, whereas the TopBP1
homologue, Dpb11, drives Mec1-Rad53 activation upon repli-
cation stress (Bastos de Oliveira et al., 2015). We established
that cell cycle– and replication stress–responsive phospho-
rylation of residues within the AAD core are critical for in-
tegrating the ATR-activating potential of ETAA1 with DNA
replication status and for its ability to suppress chromosome
instability. Recent insights into the structure of Mec1-Ddc2,
the yeast homologue of ATR-ATRIP, suggested that acidic
patches within AADs may interact with the basic C-terminal
PRD (PIKK regulatory domain) domain in Mec1/ATR to pro-
mote conformational changes associated with kinase activa-
tion (Wang et al., 2017). This offers a possible mechanistic
rationale for how negatively charged, phosphorylated resi-
dues within the ETAA1 AAD domain might enhance its ATR-
activating potential, a notion awaiting validation by biochemical
or structural approaches.
While an intra-mitotic function of ETAA1 was recently re-
ported (Bass and Cortez, 2019), the role of ETAA1 in suppressing
mitotic chromosome aberrations described here seems unlikely
to reflect such an involvement for three reasons. First, the
spectrum of mitotic chromosome abnormalities accumulating in
ETAA1Δ cells exposed to mild replication stress is characteristic
of defects arising due to the persistence of unresolved replica-
tion intermediates (Mankouri et al., 2013). Second, the stimu-
latory phosphorylations within the ETAA1 AAD, which we show
are important for its ability to suppress chromosome abnor-
malities associated with under-replicated DNA, are largely
confined to S/G2-phase cells and present at only low levels in
mitosis. Third, we did not observe significant defects in Aurora
B–associated mitotic phosphorylation events in our ETAA1Δ cell
lines (Fig. S3, D and E).
Collectively, our data suggest that whereas TopBP1 may be
the principal activator of the essential ATR-CHK1 checkpoint
pathway, the role of ETAA1 in promoting cell fitness becomes
particularly important following impediments to the DNA rep-
lication machinery that increase the risk posed by mitotic entry
in the presence of unresolved DNA replication intermediates.
This could help to explain why ETAA1 deficiency in mice man-
ifests with partially penetrant lethality during embryogenesis
and defective clonal expansion of T lymphocytes (Miosge et al.,
2017), processes entailing rapid cell proliferation where efficient
ETAA1-mediated G2/M checkpoint control may be instrumental
in suppressing gross chromosomal instability. Targeted inhibi-
tion of ETAA1 functionality might thus unmask a selective
vulnerability in highly proliferative malignant cells that gener-
ally experience deregulated control of cell cycle progression and
elevated replicative stress, providing potential opportunities for
the continued evolution of promising therapeutic strategies




Human U2OS, HCT116, HeLa, and HEK293FT cell lines obtained
from American Type Culture Collection were cultured in DMEM
containing 10% FBS and regularly tested negative for myco-
plasma infection. HeLa and HCT116 cell lines with targeted KO of
ETAA1 (ETAA1Δ), generated by transfecting parental cells with
pX459-sgETAA1 construct and selected with puromycin, were
described previously (Haahr et al., 2016). To generate derivative
cell lines inducibly expressing WT or mutant forms
(S95A+S111A, ΔRBM1+2 [Δ603-618+Δ892-926], and ΔAAD [Δ56-
220]) of GFP-tagged human ETAA1, HCT116 ETAA1Δ cells were
cotransfected with pcDNA4/TO-GFP-ETAA1 and pcDNA6/TR
(Invitrogen) plasmids, and positive clones were selected by in-
cubation in medium containing Blasticidin S (Invitrogen) and
Zeocin (Invitrogen) for 14 d.
Unless otherwise stated, the following drug concentrations
were used: thymidine (2 mM; Sigma-Aldrich), camptothecin
(1 µM; Sigma-Aldrich), HU (2 mM; Sigma-Aldrich), ATR inhib-
itor (AZ20; 1 µM; Sigma-Aldrich), APH (0.4 µM; Sigma-Aldrich),
pan-CDK inhibitor (R547; 5 µM; Sigma-Aldrich), CDK1 inhibitor
(RO-3306; 7 µM; Millipore), nocodazole (40 ng/ml), and colce-
mid (0.1 µg/ml).
Plasmids and siRNA
For doxycycline-inducible expression of GFP-ETAA1, cDNA en-
coding human ETAA1 was cloned into the destination vector
pcDNA4/TO-GFP using Gateway LR Clonase (Invitrogen). For
nuclear expression of the ETAA1 AAD, cDNA encoding residues
56–220 of human ETAA1 was inserted between the GFP and
3xNLS (nuclear localization signal) tags in the pAcGFP-Nuc
vector (Clontech), as described previously (Haahr et al., 2016).
To ensure optimal fluorescence detection, ETAA1 AAD(56–220)-
3xNLS was subcloned into pEGFP-C1 (Clontech). Introduction of
point mutations into pcDNA4/TO-GFP-ETAA1 (S95A+S111A) and
pEGFPC1-ETAA1-AAD-3xNLS (FW/AA [F106A+W107A], S95D,
S111D, S95D+S111D, T79D, and T165D) was performed using a
Q5 Site-directed mutagenesis kit (NEB), according to the man-
ufacturer’s protocol.
Plasmid DNA transfections were performed with FuGENE 6
(Promega) or GeneJuice (Merck Millipore), according to the
(E and F) Quantification of data in D (mean ± SEM; n = 3 independent experiments; 120 anaphases/condition; unpaired t test). (G) Representative images
showing breaks (indicated by arrows) on metaphase chromosomes from APH-exposed HCT116 cells treated as in A. (H) Quantification of data in G. Box plot
shows the median, upper and lower quartiles (boxes), and 10th and 90th percentiles (whiskers; 25–35 metaphases/condition; Kruskal–Wallis test). (I) Rep-
resentative images of EdU incorporation in prometaphase nuclei demarcating MiDAS in HCT116 cells treated as in A. (J) Quantification of data in I (red bars,
median; n = 3 independent experiments; 120–130 prometaphases/per condition; Kruskal–Wallis test). ****, P < 0.0001; ***, P < 0.0005; **, P < 0.005; *, P <
0.05; ns, not significant. Scale bars, 2 µm.
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Figure 3. Cell cycle– and replication stress–regulated phosphorylation of the ETAA1 AAD promotes its ATR-activating potential. (A) Sequence
alignment of the ETAA1 AAD core region. Highly conserved residues (blue) and aromatic residues required for ATR activation (asterisks) are indicated.
(B) Extracts of HCT116 cells transfected with WT or mutant versions of GFP-ETAA1 AAD were subjected to GFP IP under denaturing conditions and im-
munoblotting (IB). (C) Cells released from a G1/S arrest by double thymidine block and collected 4 h (mid-S phase), 8 h (late S), 12 h (G2-M), or 21 h (pro-
metaphase arrested with nocodazole) later were processed for IP of endogenous ETAA1 under denaturing conditions followed by IB. (D) U2OS cells transfected
with GFP-ETAA1 AAD-3xNLS constructs were immunostained with γ-H2AX antibody and analyzed by quantitative imaging to reveal single-cell correlations
between GFP expression and pan-nuclear γ-H2AX signal intensity as readout for ETAA1-induced ATR activation (Haahr et al., 2016; Thada and Cortez, 2019).
Plot shows mean γ-H2AX signal intensity in cells expressing GFP-ETAA1 AAD-3xNLS at a low level (Fig. S2 B) from a representative experiment (red bars,
median; ****, P < 0.0001, Kruskal–Wallis test; >800 cells quantified per condition). (E) HCT116 ETAA1Δ cells stably expressing GFP-ETAA1 WT or S95A+S111A
mutant were exposed or not to CPT for 90 min and subjected to GFP IP under denaturing conditions followed by IB. (F) Cells were exposed or not to CPT for
90min and processed as in C. (G) Cells incubated with CPT or HU for 90min in the presence or absence of ATR inhibitor (ATRi) were processed as in F. (H) As in
C, except that cells in late S phase (S) were treated or not with CDK inhibitor (CDKi) for 90 min before harvesting. Asyn, asynchronous cells.
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manufacturer’s instructions. For siRNA transfections (typically
48–72 h), Lipofectamine RNAiMAX (Invitrogen) was used ac-
cording to the manufacturer’s protocol. All siRNAs were used
at a final concentration of 50 nM. The following siRNA
oligonucleotides were used: non-targeting control: 59-GGGAUA
CCUAGACGUUCUA-39; MCM10, 59-GACGAUUUCUCGGAACAA
A-39; and POLE3, ON-TARGET Plus POLE3 siRNA pool (LQ-
008460-01-0002; Dharmacon; Bellelli et al., 2018).
Figure 4. Phospho-dependent regulation of ETAA1-mediated ATR activation promotes chromosome stability. (A) HCT116 ETAA1Δ cells stably re-
constituted with GFP-ETAA1 WT or mutant alleles were grown in the presence of doxycycline (Dox) to express the transgenes or kept uninduced (Fig. S3 A),
then subjected to low-dose APH treatment before synchronization in G2 and release into mitosis as in Fig. 2 A. DAPI-positive chromatin bridges were quantified
(mean ± SEM; n = 3 independent experiments; 120 anaphases/condition; unpaired t test). (B) Lagging chromatin in cells in A (mean ± SEM; n = 3 independent
experiments; 120 anaphases/condition; unpaired t test). (C) Cells in A were immunostained with PICH antibody and analyzed for PICH-coated UFBs (mean ±
SEM; n = 3 independent experiments; 150 anaphases/condition; unpaired t test). (D) Chromosome breaks in metaphase spreads of cells treated as in A were
scored. Box plot shows median, upper and lower quartiles (boxes), and 10th and 90th percentiles (whiskers; 40 metaphases/condition; Kruskal–Wallis test).
(E) As in D, but EdU foci in prometaphase were quantified (red bars, median; 120–125 prometaphases/condition; Kruskal–Wallis test). (F) As in A, using
indicated cell lines (mean ± SEM; n = 3 independent experiments; 120 anaphases/condition; unpaired t test). (G) Lagging chromatin in cells in F (mean ± SEM;
n = 3 independent experiments; 120 anaphases/condition; unpaired t test). (H) As in C, using indicated cell lines (mean ± SEM; n = 3 independent experiments;
150 anaphases/condition; unpaired t test). (I) Clonogenic survival of CPT-treated HCT116 WT and ETAA1Δ cell lines stably expressing GFP-ETAA1 WT or
S95A+S111A mutant. Results were normalized to mock treatment (mean ± SEM; n = 3 independent experiments; unpaired t test). ****, P < 0.0001; **, P <
0.005; *, P < 0.05; ns, not significant.
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Genome-scale CRISPR-Cas9 screen
For preparation of lentivirus, HEK293FT cells were transfected
with a human CRISPR KO pooled library (GeCKO v2;
1000000048; Addgene) and the lentiviral packaging plasmids
pMDLg/pRRE, pRS-Rev, and pMD2.G using Lipofectamine
3000 according to the manufacturer’s protocol. After 3 d, the
supernatant was passed through a 0.45-µm syringe filter unit,
and the multiplicity of infection was determined. HeLa WT and
ETAA1Δ cells were infected with the pooled lentiviral library at
a multiplicity of infection of 0.3 and selected with puromycin
24 h after transduction. After 2 d of puromycin selection, a
fraction of the cells was harvested (“t0” time point), and the
remaining cells were cultured for 21 d (“t21” time point). The
experiment was performed in duplicates, and library coverage
was kept at a minimum of 200× per replicate throughout the
entire screen. Genomic DNA was extracted from 3 × 107 cells as
described previously (Chen et al., 2015).
From 130 µg genomic DNA, sgRNA sequences were amplified
by PCR using Herculase II Fusion DNA polymerase kit with the
following primers: CRISPR F1, 59-AATGGACTATCATATGCTTAC
CGTAACTTGAAAGTATTTCG-39, and CRISPR R1, 59-TCTACTATT
CTTTCCCCTGCACTGTTGTGGGCGATGTGCGCTCTG-39. A second
PCR was then performed to attach Illumina adaptors and barc-
odes with primer sequences described previously (Shalem et al.,
2014).
The amplicons from the second PCR were gel-extracted and
subjected to next-generation DNA sequencing. Samples from
WT and ETAA1Δ cells were multiplexed and subjected to single-
end 75-bp-read high-throughput DNA sequencing on an Illu-
mina NextSeq instrument with 30% PhiX spike-in, generating
more than 400 million reads. Analysis of sgRNA count data was
conducted using MEMcrispR (https://github.com/grimbough/
MEMcrispR). MEMcrispR uses linear mixed-effect models for
each gene to assess the fold change and significance between two
conditions. The use of mixed effect allows addition of “fixed” and
“random” terms to the model. Days of cell growth (t0 and t21)
and the cell lines correspond to “fixed” effects, whereas the
sgRNAs and the replicates correspond to “random” effects. The
data were normalized by the median distribution of the internal
nontargeting sgRNAs. Twomodels were calculated, one with the
treatment effect (t0 versus t21) and a null model without
treatment. An ANOVA likelihood ratio test was calculated be-
tween the two models to estimate significant differences. The
data were corrected for multiple testing using the Benjamini–
Hochberg procedure. The β scores were converted to fold
changes and used for the directionality of the effect of each gene
(positive or negative) as well as for the magnitude of the effect.
Fold changes represent sgRNA read counts between treatment
and control conditions. MEMcrispR identifies differentially
represented genes between t0 versus t21 and combined, and the
advanced models use the cell line as an additional fixed pa-
rameter. Data fromMEMcrispR analysis using the cell line effect
are shown, and hits are specific to HeLa ETAA1Δ or WT cells
(q values for growth are depicted). Gene ontology enrichment
analysis was performed on the individual analyses of each
cell line. Terms were calculated by ToppGene and reduced
by Revigo.
Immunoblotting, immunoprecipitation (IP), and dot
blot analysis
For immunoblotting experiments, cells were lysed in EBC buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5%
NP-40, and 1 mM DTT) containing protease and phosphatase
inhibitors and sonicated, and the lysate was clarified by cen-
trifugation. For IP of endogenous ETAA1, cells were lysed in
denaturing buffer (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM
EDTA, 0.5% Igepal, 0.5% sodium deoxycholate, and 0.5% SDS)
supplemented with protease and phosphatase inhibitors. Cleared
lysates were incubated with ETAA1 antibody (1.5–2 µg/sample)
coupled to Protein G agarose beads (20398; Thermo Fisher Sci-
entific) overnight at 4°C on a rotary wheel. Beads with bound
proteins were washed four times with denaturing buffer and
eluted by boiling in 2× Laemmli sample buffer. GFP IPs were
performed using similar conditions, except that cell lysates were
incubatedwith GFP-Trap agarose (Chromotek) for 3 h at 4°Cwith
rotation. For dot blots, N-terminally biotin-labeled unmodified
or S95-/S111-phosphorylated peptides spanning amino acids
91–115 of human ETAA1 (SSFSSPNDPDGQNDIFWDQNSPLTK and
SSFS(pS)PNDPDGQNDIFWDQN(pS)PLTK; synthesized by Pep-
tide 2.0) were spotted onto a 0.22-µm nitrocellulose membrane
(Whatman Protran BA83). The membrane was dried for 30 min
and processed for immunoblotting.
Antibodies used in this study included mouse monoclonals to
actin (MAB1501; Millipore), cyclin A (611268; BD Biosciences),
cyclin B (610220; BD Biosciences), GFP (11814460001; Roche),
γ-H2AX (2577, Cell Signaling; and 05-636, Millipore), PICH (04-
1540; Millipore), and vinculin (V9131; Sigma-Aldrich); rabbit
polyclonals to Aurora B pT232 (600-401-677; Rockland), Chk1
pS317 (2344; Cell Signaling), FANCD2 (NB100-182; Novus Bio-
logicals), GFP (sc-8334; Santa Cruz), histone H3-pS10 (06-570;
Millipore), MCM10 (12251-1-AP; Proteintech Europe), phospho-
(Ser) CDK substrate (pSP; 2324; Cell Signaling), and phospho-
ATM/ATR substrate (pSQ; 9607; Cell Signaling). Polyclonal
phospho-specific antibodies to S95 and S111 in human ETAA1
were produced in rabbit (GenScript) using internal ETAA1
peptides as antigens. Polyclonal sheep ETAA1 antibody raised
against full-length human ETAA1 was described previously
(Haahr et al., 2016).
Immunofluorescence microscopy
Cells were washed twice in PBS before fixation with 4% form-
aldehyde for 15 min. Cells were then subjected to a per-
meabilization step with PBS containing 0.2% Triton X-100 for
5 min and incubated with primary antibodies diluted in PBS
containing 2% BSA for 1 h at room temperature. Following
incubation with secondary antibodies (Alexa Fluor; Life Tech-
nologies) diluted in PBS containing 2% BSA for 1 h at room
temperature, coverslips were mounted in Vectashield mount-
ing medium (Vector Laboratories) containing DAPI nuclear
stain (Molecular Probes). Images were acquired with a Leica
AF6000 wide-field microscope (Leica Microsystems) equipped
with HC Plan-Apochromat 63×/1.4 oil immersion objective, us-
ing standard settings. Image acquisition and analysis were per-
formed with LAS X software (Leica Microsystems). Raw images
were exported as TIFF files, and if adjustments in image contrast
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and brightness were applied, identical settings were used on all
images of a given experiment.
For high-content imaging and analysis of EGFP-ETAA1-AAD-
3xNLS expression, cells were fixed, permeabilized, and stained
as described above. Nuclear DNA was counterstained with DAPI
alongside incubation with secondary antibodies. Cells were then
mounted onto glass slides using ProLong Gold Antifade (In-
vitrogen, Molecular Probes). Images were acquired with an
Olympus IX-81 wide-field microscope equipped with an MT20
Illumination system and a digital monochrome Hamamatsu
C9100 CCD camera. Olympus UPLSAPO 10×/0.4 NA and 20×/
0.75 NA objectives were used. Automated and unbiased image
analysis was performed with the ScanR analysis software. Data
were exported and processed using Spotfire (Tibco) software.
Analysis of mitotic chromosome abnormalities
Asynchronously growing cells were mock-treated or incubated
with APH (0.4 µM) or HU (100 µM) for 14 h, and subsequently
treated with the CDK1 inhibitor (CDK1i) RO-3306 (7 µM) for 4 h.
For analysis of chromatin bridges, lagging chromatin, and UFBs,
G2-arrested cells were washed and released into fresh pre-
warmed medium for 45 min. Cells were fixed with 4% para-
formaldehyde containing 0.2% Triton X-100 in PBS for 20 min.
For MiDAS analysis, G2-arrested cells were released into fresh
medium containing EdU (20 µM) for 30min. Prometaphase cells
were gently shaken off and spotted on poly-L-lysine slides. Cells
were fixed with 4% paraformaldehyde, and the Click-iT reaction
was performed as described previously (Minocherhomji et al.,
2015). For metaphase spreads, G2-arrested cells were released
into fresh medium containing colcemid (0.1 µg/ml) for 1 h.
Mitotic cells were shaken off, treated with hypotonic buffer
(35 mM KCl) for 15 min, resuspended in methanol/acetic acid
(3:1) solution, and spread onto glass slides.
Flow cytometry
Cells collected by trypsinization were fixed in 70% ethanol,
permeabilized in 0.25% Triton X-100 for 10 min, and washed in
PBS containing 2% BSA. Cells were incubated with primary
antibodies diluted in PBS containing 2% BSA for 1 h at room
temperature, followed by a washing step in PBS containing 2%
BSA. Cells were then stained for 1 h with secondary antibody
(Alexa Fluor; Life Technologies) and washed, and DNA was
counterstained in PBS containing 0.1 mg/ml propidium iodide
containing RNase (19101; 20 µg/ml; Qiagen) for 30 min at 37°C
or, alternatively, with DAPI. Flow cytometry analysis was per-
formed using a FACS Calibur (BD Biosciences) and CellQuest Pro
software, or using a LSR Fortessa (BD Biosciences) and FACSDiva
software. Exported data were analyzed using FlowJo software
(v.10.1).
Clonogenic survival assays
For colony formation assays, cells were counted and, where
indicated, reverse-transfected with siRNAs for 48 h. Cells were
then seeded in dishes in triplicates and incubated for 7–10 d to
form visible colonies. To assay camptothecin (CPT) sensitivity,
cells were allowed to adhere for a minimum of 16 h following
seeding and then treated with 10 nM CPT for 24 h, washed, and
released into fresh medium. After 7–10 d of colony outgrowth,
plates were washed once in PBS, left to dry, and stained with cell
staining solution (0.5% wt/vol Crystal Violet; 25% vol/vol
methanol). Colonies were counted using an automated colony
counter and its associated software (GelCount; Oxford Op-
tronix). The surviving fraction was calculated as no. colonies/
(no. seeded cells × plating efficiency) and normalized to mock
control.
In vitro kinase assays
GST-tagged ETAA1(56–220) was expressed in Rosetta 2 (DE3)
pLysS bacteria and purified using glutathione-based affinity
purification. For radioactive kinase assays, 100 ng of purified
His-Cyclin A/CDK2 (PV3267; Thermo Fisher Scientific) was in-
cubated with 2 µg recombinant GST-ETAA1(56–220) in kinase
assay buffer (10 mM MnCl2, 1 mM DTT, and 50 mM β-glycero-
phosphate). Reactions were started by addition of 100 µM ATP
spiked with [γ-32P]ATP (1 µCi; Perkin Elmer), incubated at 30°C
with gentle shaking, and terminated by addition of Laemmli
sample buffer and boiling for 10 min. Samples were then re-
solved by SDS-PAGE and stained with Colloidal Blue (Life
Technologies). Relative phosphorylation was assayed by auto-
radiography. For kinase assays comparing cyclin A/CDK2 and
ATR/ATRIP kinase activity toward the ETAA1 AAD, 100 ng of
purified His–cyclin A/CDK2 or FLAG-ATR/Myc-ATRIP (14–953;
Eurofins)was incubatedwith 2 µg recombinant GST-ETAA1(56–220)
and kinase assay buffer. Samples were processed as above and
immunoblotted with phospho-specific antibodies to ETAA1 S95
and S111.
Quantification and statistical analysis
Statistical analysis of data was performed using GraphPad Prism
(version 7). Information about statistical tests is provided in the
figure legends. No samples were excluded from the analysis, and
no statistical method was used to predetermine sample size. For
all experiments, samples were not randomized, and the inves-
tigators were not blinded to the group allocation during ex-
periments and outcome assessment.
Online supplemental material
Fig. S1 shows the impact of ETAA1 deficiency on clonogenic
survival and mitotic chromosome abnormalities. Fig. S2 shows
the characterization of ETAA1 S95 and S111 phosphorylation. Fig.
S3 shows the impact of altered ETAA1 functional status on
mitotic chromosome abnormalities and Aurora B-dependent
phosphorylation events. Table S1 shows full results and analy-
sis of genome-scale CRISPR-Cas9 KO screen in HeLa WT and
ETAA1Δ cells.
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